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Background/aim: This study aimed to determine plasma thiol, disulphide, and serum ischemia-modified albumin (IMA) levels and
ferroxidase activity in patients with ascending aorta dilatation (AAD) in comparison to those without AAD and to evaluate the predictive
value of these oxidative stress parameters for AAD.
Materials and methods: This study was designed as a cross-sectional study of 184 patients who applied to our cardiology clinic. Our
study population consisted of patients with AAD (n = 85) and without AAD (n = 99). A spectrophotometric method was used to
determine plasma thiol, disulphide, and serum IMA levels and ferroxidase activity.
Results: The native thiol and the total thiol levels were significantly higher in the control group than the AAD group (P < 0.001), whereas
the disulphide and IMA levels and the ferroxidase activity were similar between the groups. The native thiol and the total thiol levels
were inversely and significantly correlated with ascending aortic diameter (r = –0.38, P < 0.001; r = –0.39, P < 0.001; respectively). The
left ventricle mass and the total thiol levels were independent predictors of ascending aortic diameter (β= 0.223, P = 0.02; β= –0.340, P
< 0.001; respectively).
Conclusion: Among oxidative stress parameters including thiols, disulphide, IMA, and ferroxidase activity, only the lower total thiol
levels appear to confer a high risk for AAD development. Along with the proven diagnostic imaging methods, thiol levels may be helpful
to diagnose and stratify patients with AAD.
Key words: Ascending aortic dilatation, oxidative stress, thiols, ferroxidase, ischemia modified albumin

1. Introduction
Ascending aortic dilatation (AAD) is a common and
incidental condition, which can be fatal if unnoticed at
an early stage. The enlargement of the ascending aorta
is defined as aneurysm if it is over 1.5 times the normal
diameter. As it is a clinically silent disease, it is difficult
to assess the true prevalence and incidence of aortic
aneurysms. Aortic aneurysms are associated with a rupture
risk of more than 5% per year resulting in death [1].
Several mechanisms have been shown to be linked with
the development of AAD such as hemodynamic force,
destructive remodeling of the extracellular matrix, familial
predisposition, transmural inflammation of the aorta, and
oxidative stress [2–5]. Particularly, the imbalance between
matrix metalloproteinases (MMPs) and their inhibitors
plays an important role in the degradation of the structure of
aortic wall and the development of aortic aneurysms [5,6].

Thiols are mercaptans consisting of sulfhydryl groups.
They are mostly formed by albumin, proteins, and lowmolecular weight molecules and switched to disulphide
bonds under oxidative process through a reversible
reaction. Abnormal thiol disulphide homeostasis is related
to various cardiovascular diseases including coronary
artery disease, primary hypertension, heart failure, and
pulmonary hypertension and embolism [7-10]. When free
oxygen radical-induced cell membrane damage occurs in
cases of acidosis and hypoxia, serum albumin undergoes
modification and its metal binding capacity decreases. This
deformed albumin is called ischemia-modified albumin
(IMA). It is an important biomarker for the identification
of ischemic conditions such as coronary artery disease and
oxidative stress-related diseases including diabetes mellitus
(DM), hypercholesterolemia, and metabolic syndrome
[11,12]. Ceruloplasmin, which is an extracellular major
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antioxidant molecule that prevents ferrous ion-induced
lipid peroxidation through ferroxidase activity, was shown
to be a marker of cardiovascular risk [13,14]. The role of
oxidative stress parameters including thiol, disulphide,
IMA, and ferroxidase activity in AAD development and
their capability as a biomarker utilization is not wellknown. In this study, we aimed to determine plasma thiol,
disulphide, and serum IMA levels and ferroxidase activity
in patients with AAD in comparison to those without
AAD and to evaluate the predictive value of these oxidative
stress markers for AAD.
2. Materials and methods
2.1. Patient sample and definitions
This study was designed as a cross-sectional study of 184
consecutive patients who applied to our cardiology clinic
from February 2018 to July 2018. Our study population
consisted of patients with AAD (n = 85) and control group
patients without AAD (n = 99). The inclusion criteria were
as follows: being older than 18 years of age, accepting to
participate in the study, and patients being diagnosed with
AAD. The exclusion criteria were defined as patients with
moderate to severe valve disease, prosthetic heart valve,
bicuspid aortic valve morphology, an infectious disease,
malignancy, pulmonary embolism, accompanying acute
aortic and coronary syndromes, decompensated heart
failure, more than mild hepatic or renal disease, and
patients taking drugs with antioxidant effects. Additionally,
patients with myocarditis, pericarditis, cardiomyopathy,
Marfan syndrome, hepatotoxic drug use, biliary tract
diseases, and secondary hypertension were excluded from
the study.
The age, sex, medical history, cardiovascular risk
factors, medications, physical examination findings, and
basic laboratory analyses including complete blood count
and standard biochemical parameters of all the patients
were recorded electronically. Hypertension was defined
as systolic blood pressure ≥140 mmHg or diastolic blood
pressure ≥90 mmHg in at least 3 office measurements or
as using antihypertensive therapy. DM was defined as
blood glucose ≥126 mg/dl or as using antidiabetic drugs.
Regardless of the amount, active smokers were defined as
smoker. Body mass index (BMI) and body surface area
(BSA) were calculated with the Mosteller formula.
The recommendations of the Good Clinical Practices
Guidelines and the Declaration of Helsinki were followed
during the study.
2.2. Blood samples and laboratory measurements
Blood samples for the measurement of biochemical
parameters were obtained at least after 8 hours of
overnight fasting. Blood samples were taken from a cubital
vein and biochemical parameter analyses were performed
with Hitachi 747 autoanalyzer. The plasma samples were
taken into EDTA/citrated tubes. On the other hand, serum
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samples were taken into tubes without EDTA/citrate.
Plasma concentrations of total cholesterol, triglyceride,
low-density lipoprotein (LDL) cholesterol, and highdensity lipoprotein (HDL) cholesterol were calculated by
enzymatic chemical cleaning method using Cobas 6000
(Roche Diagnostics GmbH, Mannheim, Germany).
A spectrophotometric method was used to determine
the plasma thiol and disulphide levels as described
previously by Erel et al. [15]. The serum IMA levels were
measured automatically by a colorimetric method as
described by Bar-Or et al. [16]. The serum ferroxidase
activity was determined with a Hitachi 912 analyzer
(Roche Diagnostics GmbH) according to the method
described by Erel [17].
2.3. Echocardiographic measurements
All the participants underwent comprehensive twodimensional, M-mode, and Doppler echocardiographic
examinations performed by one experienced research
echocardiographer, who was blinded to the study protocol.
Echocardiographic examinations were performed by
using a commercially available echocardiograph equipped
with a 2.5- and 3.5-MHz transducer with Philips iE33
xMatrix (Philips Healthcare, Inc., Andover, MA). The
left ventricular ejection fraction (LVEF) was calculated
from the parasternal long axis images using the M-mode
method. The left ventricular (LV) mass was measured
using the Devereux formula [18]. The diameter of the
ascending aorta (DAA) was measured by the leading-edge
method from parasternal long-axis view in accordance
with the European Society of Echocardiography guidelines
[19]. AAD was defined as DAA above 3.7 cm.
2.4. Statistical analysis
The statistical analyses were carried out using IBM
SPSS Statistics for Macintosh, Version 24.0 (IBM Corp.,
Armonk, NY, USA). The one-sample Kolmogorov–
Smirnov test was used to evaluate the distribution of
numerical variables. According to the results of this test,
the Student’s t-test was applied to the numerical data
which conforms to the normal distribution and the results
were entered as mean and standard deviation. On the
other hand, the Mann–Whitney U test, which is one of the
nonparametric tests, was used for the skewed distributed
variables. Considering the results of this test, the median
and interquartile range values were used. The chi-square
test was used for categorical variables. The Fisher’s exact
test was applied in cases where the chi-square test could
not be applied. For correlation analyses regarding AAD,
the Pearson’s correlation analyses were preferred for
data with normal distribution, otherwise Spearman’s
correlation analyses were preferred for data with skewed
distribution. Independent relationships of maximal aortic
diameter were assessed by stepwise linear regression
analyses. The variables which were significantly correlated
with DAA and the variables known to be associated
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with AAD were included in the analyses. Afterwards,
BMI, glomerular filtration rate (GFR), LVEF, and left
atrium diameter (LAd) were applied into the first model.
Hierarchically, the LV mass and the plasma total thiol levels
were added into Model 2 and Model 3, respectively. The
multicollinearity assessment was checked with correlation
coefficient (r) and the variance inflation factor (VIF)
value. Independent variables with a correlation coefficient
(r) above 0.7 and a VIF value above 3 were considered to
have multicollinearity and were not included in the same
model. Receiver operating characteristic (ROC) curve
analyses were used to determine the cut-off values for

the sensitivity and specificity of the total thiol levels in
predicting AAD. P values lower than 0.05 were considered
to be statistically significant.
3. Results
Table 1 presents baseline characteristics and laboratory
parameters including oxidative stress parameters of the
study groups. Age, BMI, BSA, the presence of hypertension
and DM, smoking status, glucose levels, LDL, triglyceride,
neutrophil, lymphocyte, neutrophil to lymphocyte ratio
(NLR), and thyroid stimulating hormone levels were
similar between the groups. The total cholesterol and HDL

Table 1. Baseline characteristics and laboratory parameters of the patients.
Variables

Normal ascending aortic
diameter (n = 99)

Dilated ascending aortic
diameter (n = 85)

p value

Age, years

65.1 ± 9.6

65.9 ± 9.0

0.60

Sex (male), n (%)

67 (67)

54 (53)

0.55

BMI (kg/m2)

28.1 (5.1)

29.4 (6.1)

0.06

BSA (m2)

1.9 (0.2)

1.89 (0.2)

0.75

Hypertension, n (%)

61 (61)

62 (72)

0.10

Diabetes mellitus, n (%)

30 (30)

29 (34)

0.58

Smoking, n (%)

24 (24)

21 (24)

0.94

Glucose (mg/dL)

102 (28)

105 (59)

0.32

Total cholesterol (mg/dL)

188.8 ± 42.5

175.1 ± 48.1

0.04*

HDL (mg/dL)

43 (12.2)

40.9 (18.3)

0.01*

LDL (mg/dL)

112.5 ± 37.7

101.7 ± 37.6

0.05

Triglycerides (mg/dL)

138 (116)

126 (96)

0.49

Creatinine (mg/dL)
GFR (mL/min/ m2)

0.82 (0.28)

0.94 (0.41)

0.001*

88 (26)

77 (39)

<0.001*

Neutrophil (K/uL)

4370 (1800)

4450 (2620)

0.88

Lymphocyte (K/uL)

2260 ± 776

2094 ± 859

0.17

NLR

2.07 (1.35)

2.1 (2.25)

0.26

TSH (uIU/mL)

1.5 (1.5)

1.4 (1.3)

0.36

Native thiol (µmol/L)

439.2 ± 64.6

372.1 ± 73.9

<0.001*

Total thiol (µmol/L)

469.3 ± 64.1

403.1 ± 64.1

<0.001*

Disulphide (µmol/L)

16.2 (12.7)

15.3 (13.3)

0.23

Disulphide/Native thiol

0.04 (0.03)

0.04 (0.03)

0.79

Disulphide/Total thiol

0.03 (0.03)

0.04 (0.03)

0.80

Native thiol/Total thiol

0.93 (0.06)

0.92 (0.06)

0.86

Ferroxidase (U/L)

465 (186)

498(210)

0.12

IMA (ABSU)

75.7 ± 4.3

75.2 ± 5.9

0.53

BMI: Body mass index; BSA: Body surface area; GFR: Glomerular filtration rate; HDL: High-density lipoprotein;
IMA: Ischemic modified albumin; IQR: Interquartile range; LDL: Llow-density lipoprotein; NLR: Neutrophil
to lymphocyte ratio; SD: Standard deviation; TSH: Thyroid stimulating hormone. Parameters were expressed as
mean ± SD and median [IQR].
*P < 0.05 was considered significant for statistical analyses.
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levels and GFR were significantly higher in the control
group (P = 0.04, P = 0.01, P < 0.001, respectively), whereas
the creatinine levels were significantly lower in the control
group compared to the AAD patient group (P = 0.001).
The native thiol and the total thiol levels were significantly
lower in the AAD group than the control group (372.1 ±
73.9, 439.2 ± 64.6, P < 0.001; 403.1 ± 64.1, 469.3 ± 64.1, P <
0.001; respectively). The other oxidative stress parameters
such as disulphide, IMA levels, and ferroxidase activity
were similar among the groups.
Table 2 presents the echocardiographic measurements
of the study population. The patients with AAD had
significantly lower LVEF values compared to the control
group patients, whereas the LV end-diastolic diameter,
LAd, the diameters of end-diastolic interventricular
septum and posterior wall, and the LV mass and LV mass
index were significantly higher in the AAD patients.
Table 3 shows the correlation analyses of DAA with
various variables. The native thiol and the total thiol levels
were significantly and inversely correlated with DAA (r =
–0.38, P < 0.001; r = –0.39, P < 0.001; respectively) (Figure).
In a similar manner, GFR and LVEF were inversely
correlated with DAA with statistical significance. On the
other hand, BMI, the LV mass, and LAd were positively
and significantly correlated with DAA.
Stepwise linear regression analysis, which is also given
in Table 4, showed that the LV mass and the plasma total
thiol levels are independent predictors of DAA (β = 0.223,
P = 0.02; β = –0.340, P < 0.001, respectively). The area
under the ROC curve for the total thiol level predicting
AAD was 0.755 (95% CI: 0.687–0.823, P < 0.001). The cutoff value of the total thiol level (436.3) was associated with
69% sensitivity and 62% specificity for AAD.

4. Discussion
In this study, the plasma total thiol and the native thiol
levels, which are the indicators of oxidative stress, were
lower in the AAD patients compared to the control
group patients with normal DAA. In addition, the plasma
total thiol level and the LV mass were demonstrated to
be distinctive factors of DAA. However, there was no
difference in disulphide and IMA levels or ferroxidase
activity between the groups.
Oxidative stress is defined as tissue damage occurring
secondary to increased production and/or decreased
destruction of reactive oxygen species (ROS). The
nicotinamide adenine dinucleotide phosphate oxidase and
xanthine oxidase pathways are responsible for vascular
oxidative stress [3]. Beyond traditional risk factors for
aortic aneurysms such as advanced age, hypertension,
and smoking, MMPs and ROS are also considered to be
important risk factors in the pathophysiology of AAD
[20,21]. In a recent study published by Akkuş et al., the
native thiol and the total thiol levels were demonstrated
to correlate moderately with maximal aortic diameter.
The total thiol level was also found to be an independent
predictor of maximal aortic diameter in this study, and it
was observed that the thiol levels increased after surgical
repair of the aorta [1]. Likewise, the total and native thiol
levels were lower in the patients with AAD in our study.
Our study group consisted of a relatively high number
of patients when compared to the study of Akkuş et al.,
and the patients in our study tended to be older, which
is a significant contributor to oxidative stress. We also
investigated the role of disulphide, IMA levels, and
ferroxidase activity in our population, although there was
no difference between the groups. We used transthoracic

Table 2. Echocardiographic measurements of the study population.
Variables

Normal ascending aortic
diameter (n = 99)

Dilated ascending aortic
diameter (n = 85)

P value

LVEDD (mm)

47 (4)

49 (7.5)

0.01*

Lad (mm)

39 (6)

43 (8)

<0.001*

LVEF (%)

60 (11)

55 (13)

0.001*

IVSd (mm)

12 (2)

12 (3)

0.002*

PWd (mm)

11 (2)

12 (1)

0.004*

LV mass (g)

204 (54)

234 (72)

<0.001*

LV mass index (g/m )

105 (22)

123 (31)

<0.001*

Ascending aorta (mm)

34 (4)

41 (3)

<0.001*

2

IQR: Interquartile range; IVSd: End-diastolic interventricular septum diameter; Lad: Left atrium diameter; LV
mass: Left ventricle mass; LVEDD: Left ventricle end-diastolic diameter; LVEF: Left ventricle ejection fraction;
PWd: End-diastolic posterior wall diameter; SD: Standard deviation. Parameters were expressed as mean ± SD
and median [IQR].
*A P value less than 0.05 was considered significant for statistical analyses.
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Table 3. Ascending aortic diameter and their correlation with
variables.

Variables

Ascending aortic diameter
r coefficient

P value

Age

0.09

0.21

GFR

–0.24

0.001*

BMI

0.15

0.03*

Glucose

0.07

0.32

Total cholesterol

–0.11

0.11

HDL

–0.14

0.05

LDL

–0.11

0.13

Triglycerides

–0.01

0.85

NLR

0.12

0.08

LVEF

–0.19

0.008*

LV mass

0.37

<0.001*

LAd

0.35

<0.001*

Native thiol

–0.38

<0.001*

Total thiol

–0.39

<0.001*

Disulphide

–0.09

0.18

Ferroxidase

0.13

0.06

IMA

–0.008

0.91

BMI: Body mass index; GFR: Glomerular filtration rate; HDL:
High-density lipoprotein; IMA: Ischemic modified albumin; Lad:
Left atrium diameter; LV mass: Left ventricle mass; LVEDD: Left
ventricle end diastolic diameter; LVEF: Left ventricle ejection
fraction; LDL: Low-density lipoprotein; NLR: Neutrophil to
lymphocyte ratio.
*A P value less than 0.05 was considered significant for statistical
analyses.

echocardiography to evaluate the ascending aorta, and
AAD was defined as a DAA above 3.7 cm. However, Akkuş
et al. applied computed tomography in their study, and they
included patients with thoracic aorta enlargement above
4.0 cm. Due to our study design, we did not investigate
whether the treatment improved thiol levels, and we also
excluded patients with acute aortic syndrome.
Unlike previously published studies, we investigated
the role of other oxidative stress parameters, including
disulphide, IMA levels, and ferroxidase activity. However,
these parameters were comparable among the groups.
There are no studies in the literature investigating the
relationship between aortic pathologies and ferroxidase
activity, and data evaluating the IMA levels in this patient
group are limited and have contradictory results. A previous
study reported that there was no difference between the
IMA levels in the aortic dissection and aneurysm groups

compared to the healthy control group [22]. Conversely,
a study by Eroğlu et al. demonstrated that the IMA levels
were higher in the aortic aneurysm group than the control
group [23]. These contradictory results may be due to the
differences in number, age, demographic characteristics,
sex, and race of the patients included in the studies. In
our study, we did not observe any significant difference
regarding the serum IMA levels between the AAD group
and the control group. There may be several reasons for
comparable IMA levels while thiol levels are altered in
AAD patients. The first may be related to the different rates
of biochemical kinetics of these oxidative stress parameters.
There are no data on the time periods required for changes
in thiol-disulphide homeostasis and ferroxidase activity. In
studies of coronary artery disease, the IMA levels increased
immediately after exposure to ischemia and decreased to
normal levels within 12 hours [22]. Another reason that
may explain this difference may be the rate of exposure
to physiological variables, which significantly affects the
IMA levels [23]. Finally, it may be necessary to have more
severe oxidative damage, such as ischemia, acidosis, or
tissue hypoxia, in order to change the IMA and ferroxidase
activity. In the case of AAD, the oxidative process is a
progressive condition that spreads over a longer period of
time, but to a lesser degree compared to acute conditions.
There are various limitations of our study. Our study
includes a relatively small population recruited from a single
center. Large-scale epidemiological studies conducted
over several years are required to correlate the crosssectional findings from this study with clinical outcomes.
The association between AAD and various oxidative stress
markers, such as uric acid, gamma-glutamyl transferase,
asymmetric dimethylarginine, alpha-1 antitrypsin,
C-reactive protein, interleukin-6, and NLR, has previously
been shown by different methods in the literature [2, 24–
29]. Although there was no difference between the groups in
terms of NLR in our study population, we did not evaluate
all of the oxidative stress parameters. In addition, only the
transthoracic echocardiography measurements were used
as diagnostic imaging methods. Computed tomography,
magnetic resonance imaging, and transesophageal
echocardiography measurements can detect aortic
aneurysms in other anatomic locations and improve the
accuracy of ascending aortic measurements. Lastly, low
thiol levels may not only be a suspicious precipitating factor
of aortic enlargement, but also a by-product of dilatation.
In conclusion, among oxidative stress parameters
including thiols, disulphide, IMA, and ferroxidase activity,
only lower total thiol levels appear to confer a high risk
for AAD development. Along with the proven diagnostic
imaging methods, thiol levels may be helpful to diagnose
and stratify patients with AAD. Pathophysiological and
biochemical mechanisms of oxidative stress during AAD
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Figure. The relationship between ascending aorta diameter and thiol levels.
Table 4. Stepwise linear regression analyses for ascending aortic diameter.

Variables

Model II
Adjusted R2 = 0.160
R square change: 0.05

Model I
Adjusted R2 = 0.115

Model III
Adjusted R2 = 0.243
R square change: 0.09

Standardized
Collinearity
Standardized
Collinearity
Standardized
Collinearity
P value
P value
P value
β
statistics (VIF) β
statistics (VIF) β
statistics (VIF)
LVEF

–0.097

0.20

1.22

-0.052

0.49

1.26

–0.002

0.98

1.29

GFR

–0.205

0.01*

1.20

–0.174

0.02*

1.11

–0.041

0.34

1.32

LAd

0.166

0.03*

1.09

0.092

0.23

1.31

0.071

0.58

1.32

BMI

0.136

0.06

1.04

0.122

0.08

1.04

0.085

0.20

1.06

0.249

0.001* 1.25

0.223

0.002*

1.26

–0.340

<0.001* 1.36

LV mass
Total Thiol

Stepwise linear regression analysis. The regression model included body mass index (BMI), glomerular filtration rate (GFR), left atrium
diameter (LAd), left ventricular ejection fraction (LVEF, %), left ventricle mass (LV-mass) and total thiol as possible independent
variables. Standardized β: Beta c oefficient; VIF: Variance inflation factor.

development may be identified with the help of future
studies.
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